AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | 0.0% | 118 | +21.6% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 97 | -44.3% | 0.00% | – |
| Q4 2021 | $5,000 | +25.0% | 174 | +100.0% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 87 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 87 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | -40.0% | 87 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 87 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -57.1% | 87 | -37.0% | 0.00% | – |
| Q4 2019 | $7,000 | -94.2% | 138 | -92.3% | 0.00% | -100.0% |
| Q1 2019 | $120,000 | +50.0% | 1,781 | +2.8% | 0.00% | +100.0% |
| Q4 2018 | $80,000 | -40.3% | 1,733 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $134,000 | – | 1,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |